佐力药业：2025年半年度归属于上市公司股东的净利润同比增长26.16%

Group 1 - The core viewpoint of the article is that Zhaoli Pharmaceutical reported significant growth in both revenue and net profit for the first half of 2025, indicating a positive financial performance [2] Group 2 - The company achieved operating revenue of 1,599,453,446.18 yuan, representing a year-on-year increase of 11.99% [2] - The net profit attributable to shareholders of the listed company was 373,500,159.82 yuan, reflecting a year-on-year growth of 26.16% [2]